Prior knowledge for time domain quantification of in vivo brain or liver 31P MR spectra

NMR in Biomedicine

Volumn 16, Issue 3, 2003, Pages 168-176

  Hamilton, Gavin ^a,b   Patel, Nayna ^a,b   Forton, Daniel M ^a,b   Hajnal, Joseph V ^a   Taylor Robinson, Simon D ^a,b  

^a MRC CLINICAL SCIENCES CENTRE   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Phosphorus 31 magnetic resonance spectroscopy; Prior knowledge; Quantification; Spectral analysis; Time domain

Indexed keywords

MAGNETIC RESONANCE SPECTROSCOPY; NEUROLOGY; PATIENT MONITORING;

TIME DOMAIN QUANTIFICATION;

BRAIN;

ESTER; PHOSPHORUS 31;

ARTICLE; BRAIN; DATA ANALYSIS; HUMAN; HUMAN EXPERIMENT; IN VIVO STUDY; LIVER; NORMAL HUMAN; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SPECTROSCOPY;

ALGORITHMS; BRAIN CHEMISTRY; COMPUTER SIMULATION; HUMANS; LIVER; MAGNETIC RESONANCE IMAGING; MODELS, BIOLOGICAL; MODELS, STATISTICAL; PHOSPHORUS COMPOUNDS; PHOSPHORUS ISOTOPES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 0042129985     PISSN: 09523480     EISSN: None     Source Type: Journal    
DOI: 10.1002/nbm.821     Document Type: Article

References (33)

1. 31P brain spectra. NMR Biomed. 1999; 12: 8-14.
2. Mierisova S, Ala-Korpela M. MR spectroscopy quantitation: a review of frequency domain methods. NMR Biomed. 2001; 14: 247-259.
3. Bottomley PA, Hart HR, Edelstein WA, Schenk JF, Smith LS, Leue WM, Mueller OM. Anatomy and metabolism of the normal human brain studied by magnetic resonance at 1.5 Tesla. Radiology 1984; 150: 441-446.
4. Cox IJ. Development and applications of in vivo clinical magnetic resonance spectroscopy. Prog. Biophys. Mol. Biol. 1996; 65: 45-81.
5. 31P NMR ex vivo pig liver studies. NMR Biomed. 1999; 12: 197-204.
6. Ruiz-Cabello J, Cohen JS. Phospholipid metabolites as indicators of cancer cell function. NMR Biomed. 1992; 5: 226-233.
7. 1H-NMR investigation in vitro of normal and abnormal human liver. Biochim. Biophys. Acta 1993; 1225: 71-77.
8. 31P nuclear magnetic resonance study. Biochim. Biophys. Acta 1995; 1272: 113-118.
9. 31P NMR spectra in vivo. Magn. Reson. Med. 1989; 12: 282-289.
10. Bell JD, Taylor-Robinson SD. Assessing gene expression in vivo: magnetic resonance imaging and spectroscopy. Gene Ther. 2000; 7: 1259-1264.
11. Helms G, Piringer A. Restoration of motion-related signal loss and line-shape deterioration of proton MR spectra using the residual water as intrinsic reference. Magn. Reson. Med. 2001; 46: 395-400.
12. in't Zandt H, van Der Graaf M, Heerschap, A. Common processing of in vivo MR spectra. NMR Biomed. 2001; 14: 224-232.
13. Van Hecke P, Van Huffel S. NMR Spectroscopy Quantification. NMR Biomed. 2001; 14: 223.
14. Vanhamme L, Sundin T, Van Hecke P, Van Huffel S. MR spectroscopy quantitation: a review of time-domain methods. NMR Biomed. 2001; 14: 233-246.
15. Ordidge RJ, Bowley RM, McHale G. A general approach to selection of multiple cubic volume elements using the ISIS technique. Magn. Reson. Med. 1988; 8: 323-331.
16. Saeed N, Menon DK. A knowledge-based approach to minimize baseline roll in chemical shift imaging. Magn. Reson. Med. 1993; 29: 591-598.
17. Vanhamme L, van den Boogaart A, Van Huffel S. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J. Magn. Reson. 1997; 129: 35-43.
18. van den Boogaart A, Van Hecke P, Van Huffel S, Graveron-Demilly D, van Ormondt D, de Beer R. MRUI: a graphical user interface for accurate routine MRS data analysis. Proceedings of the ESMRMB 13th Annual Meeting, Prague, 1996; 318.
19. van den Boogaart, A. MRUI Manual V.96.3. A User's Guide to the Magnetic Resonance User Interface Software Package. Delft Technical University Press: Delft, 1997.
20. Changani KK, Jalan R, Cox IJ, Ala-Korpela M, Bhakoo K, Taylor-Robinson SD, Bell JD. Evidence for altered hepatic gluconeogenesis in patients with cirrhosis using in vivo 31-phosphorus magnetic resonance spectroscopy. Gut 2001; 49: 557-564.
21. Cavassila S, Deval S, Huegen C, Van Ormondt D, Graveron-Demilly D. The beneficial influence of prior knowledge on the quantitation of in vivo magnetic resonance spectroscopy signals. Invest. Radiol. 1999; 34: 242-246.
22. 31P magnetic resonance spectroscopy study. Hepatology 2002; 35: 421-424.
23. 31P-MR spectroscopy. Hepatology 2002; 36: 345-353.
24. Menon DK, Sargentoni J, Taylor-Robinson SD, Bell JD, Cox IJ, Bryant DJ, Coutts GA, Rolles K, Burroughs AK, Morgan MY. Effect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: biochemical basis of spectral appearances. Hepatology 1995; 21: 417-427.
25. Taylor-Robinson SD, Sargentoni J, Mallalieu RJ, Bell JD, Bryant DJ, Coutts GA, Morgan MY. Cerebral phosphorus-31 magnetic resonance spectroscopy in patients with chronic hepatic encephalopathy. Hepatology 1994; 20: 1173-1178.
26. 1-weighted contrast measurements with abnormalities in proton and phosphorus-31 MR spectra. Metab. Brain Dis. 1996; 11: 249-268.
27. Taylor-Robinson SD, Buckley C, Changani KK, Hodgson HJ, Bell JD. Cerebral proton and phosphorus-31 magnetic resonance spectroscopy in patients with subclinical hepatic encephalopathy. Liver 1999; 19: 389-398.
28. Mathur R, Cox IJ, Oatridge A, Shephard DT, Shaw RJ, Taylor-Robinson SD. Cerebral bioenergetics in stable chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1999; 160: 1994-1999.
29. Hamilton G, Mathur R, Allsop JM, Forton DM, Dhanjal NS, Shaw R, Taylor-Robinson SD. Changes in brain intracellular pH and membrane phospholipids; on oxygen therapy in hypoxic patients with chronic obstructive pulmonary disease. Metab. Brain Dis. 2003; 18: 95-109.
30. 31P MRS study. Alcohol. Clin. Exp. Res. 2001; 25: 89-97.
31. 31p magnetic resonance spectroscopy and electron microscopy of the cirrhotic liver. Liver 1997; 17: 198-209.
32. Richardson AJ, Allen SJ, Hajnal JV, Cox IJ, Easton T, Puri BK. Associations between central and peripheral measures of phospholipid breakdown revealed by cerebral 31-phosphorus magnetic resonance spectroscopy and fatty acid composition of erythrocyte membranes. Prog. Neuropsychopharmac. Biol. Psychiat. 2001; 25: 1513-1521.
33. 31P MR spectroscopy assessed liver metabolite concentrations from different institutions. Magn. Reson. Imag. 1998; 16: 205-211.